 This study found that there was no significant difference in the incidence of postoperative pulmonary complications, PPCs, between patients who received sugemaidex or neostigmine as reversal agents during video-assisted thoracoscopic surgery, that's lobectomy. Additionally, neither agent had any effect on the length of hospital stay or intensive care unit, ICU, admission. This article was authored by Taeyun Lee, Songyup Jong, Junho Jong, and others.